Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.
Identifieur interne : 000345 ( PubMed/Corpus ); précédent : 000344; suivant : 000346Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.
Auteurs : Anass Abbad ; Ranawaka Apm Perera ; Latifa Anga ; Abdellah Faouzi ; Nhu Nguyen Tran Minh ; Sk Md Mamunur Rahman Malik ; Nadia Iounes ; Abderrahmane Maaroufi ; Maria D. Van Kerkhove ; Malik Peiris ; Jalal NourlilSource :
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [ 1560-7917 ] ; 2019.
Abstract
BackgroundMiddle East respiratory syndrome coronavirus (MERS-CoV) remains a major concern for global public health. Dromedaries are the source of human zoonotic infection. MERS-CoV is enzootic among dromedaries on the Arabian Peninsula, the Middle East and in Africa. Over 70% of infected dromedaries are found in Africa. However, all known zoonotic cases of MERS have occurred in the Arabian Peninsula with none being reported in Africa.AimWe aimed to investigate serological evidence of MERS-CoV infection in humans living in camel-herding areas in Morocco to provide insights on whether zoonotic transmission is taking place.MethodsWe carried out a cross sectional seroprevalence study from November 2017 through January 2018. We adapted a generic World Health Organization MERS-CoV questionnaire and protocol to assess demographic and risk factors of infection among a presumed high-risk population. ELISA, MERS-CoV spike pseudoparticle neutralisation tests (ppNT) and plaque neutralisation tests (PRNT) were used to assess MERS-CoV seropositivity.ResultsSerum samples were collected from camel slaughterhouse workers (n = 137), camel herders (n = 156) and individuals of the general population without occupational contact with camels but living in camel herding areas (n = 186). MERS-CoV neutralising antibodies with ≥ 90% reduction of plaque numbers were detected in two (1.5%) slaughterhouse workers, none of the camel herders and one individual from the general population (0.5%).ConclusionsThis study provides evidence of zoonotic transmission of MERS-CoV in Morocco in people who have direct or indirect exposure to dromedary camels.
DOI: 10.2807/1560-7917.ES.2019.24.48.1900244
PubMed: 31796154
Links to Exploration step
pubmed:31796154Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.</title><author><name sortKey="Abbad, Anass" sort="Abbad, Anass" uniqKey="Abbad A" first="Anass" last="Abbad">Anass Abbad</name><affiliation><nlm:affiliation>These authors contributed equally to this work.</nlm:affiliation></affiliation></author><author><name sortKey="Perera, Ranawaka Apm" sort="Perera, Ranawaka Apm" uniqKey="Perera R" first="Ranawaka Apm" last="Perera">Ranawaka Apm Perera</name><affiliation><nlm:affiliation>These authors contributed equally to this work.</nlm:affiliation></affiliation></author><author><name sortKey="Anga, Latifa" sort="Anga, Latifa" uniqKey="Anga L" first="Latifa" last="Anga">Latifa Anga</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Faouzi, Abdellah" sort="Faouzi, Abdellah" uniqKey="Faouzi A" first="Abdellah" last="Faouzi">Abdellah Faouzi</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Minh, Nhu Nguyen Tran" sort="Minh, Nhu Nguyen Tran" uniqKey="Minh N" first="Nhu Nguyen Tran" last="Minh">Nhu Nguyen Tran Minh</name><affiliation><nlm:affiliation>Health Emergencies Programme, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.</nlm:affiliation></affiliation></author><author><name sortKey="Malik, Sk Md Mamunur Rahman" sort="Malik, Sk Md Mamunur Rahman" uniqKey="Malik S" first="Sk Md Mamunur Rahman" last="Malik">Sk Md Mamunur Rahman Malik</name><affiliation><nlm:affiliation>Health Emergencies Programme, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.</nlm:affiliation></affiliation></author><author><name sortKey="Iounes, Nadia" sort="Iounes, Nadia" uniqKey="Iounes N" first="Nadia" last="Iounes">Nadia Iounes</name><affiliation><nlm:affiliation>Laboratoire d'Ecologie et d'Environnement, Faculté des Sciences Ben M'Sik, Université Hassan II, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Maaroufi, Abderrahmane" sort="Maaroufi, Abderrahmane" uniqKey="Maaroufi A" first="Abderrahmane" last="Maaroufi">Abderrahmane Maaroufi</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><affiliation><nlm:affiliation>Health Emergencies Programme, World Health Organization, Geneva, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name><affiliation><nlm:affiliation>HKU-Pasteur Research Pole, University of Hong Kong, Hong Kong SAR, China.</nlm:affiliation></affiliation></author><author><name sortKey="Nourlil, Jalal" sort="Nourlil, Jalal" uniqKey="Nourlil J" first="Jalal" last="Nourlil">Jalal Nourlil</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:31796154</idno><idno type="pmid">31796154</idno><idno type="doi">10.2807/1560-7917.ES.2019.24.48.1900244</idno><idno type="wicri:Area/PubMed/Corpus">000345</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000345</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.</title><author><name sortKey="Abbad, Anass" sort="Abbad, Anass" uniqKey="Abbad A" first="Anass" last="Abbad">Anass Abbad</name><affiliation><nlm:affiliation>These authors contributed equally to this work.</nlm:affiliation></affiliation></author><author><name sortKey="Perera, Ranawaka Apm" sort="Perera, Ranawaka Apm" uniqKey="Perera R" first="Ranawaka Apm" last="Perera">Ranawaka Apm Perera</name><affiliation><nlm:affiliation>These authors contributed equally to this work.</nlm:affiliation></affiliation></author><author><name sortKey="Anga, Latifa" sort="Anga, Latifa" uniqKey="Anga L" first="Latifa" last="Anga">Latifa Anga</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Faouzi, Abdellah" sort="Faouzi, Abdellah" uniqKey="Faouzi A" first="Abdellah" last="Faouzi">Abdellah Faouzi</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Minh, Nhu Nguyen Tran" sort="Minh, Nhu Nguyen Tran" uniqKey="Minh N" first="Nhu Nguyen Tran" last="Minh">Nhu Nguyen Tran Minh</name><affiliation><nlm:affiliation>Health Emergencies Programme, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.</nlm:affiliation></affiliation></author><author><name sortKey="Malik, Sk Md Mamunur Rahman" sort="Malik, Sk Md Mamunur Rahman" uniqKey="Malik S" first="Sk Md Mamunur Rahman" last="Malik">Sk Md Mamunur Rahman Malik</name><affiliation><nlm:affiliation>Health Emergencies Programme, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.</nlm:affiliation></affiliation></author><author><name sortKey="Iounes, Nadia" sort="Iounes, Nadia" uniqKey="Iounes N" first="Nadia" last="Iounes">Nadia Iounes</name><affiliation><nlm:affiliation>Laboratoire d'Ecologie et d'Environnement, Faculté des Sciences Ben M'Sik, Université Hassan II, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Maaroufi, Abderrahmane" sort="Maaroufi, Abderrahmane" uniqKey="Maaroufi A" first="Abderrahmane" last="Maaroufi">Abderrahmane Maaroufi</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><affiliation><nlm:affiliation>Health Emergencies Programme, World Health Organization, Geneva, Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name><affiliation><nlm:affiliation>HKU-Pasteur Research Pole, University of Hong Kong, Hong Kong SAR, China.</nlm:affiliation></affiliation></author><author><name sortKey="Nourlil, Jalal" sort="Nourlil, Jalal" uniqKey="Nourlil J" first="Jalal" last="Nourlil">Jalal Nourlil</name><affiliation><nlm:affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title><idno type="eISSN">1560-7917</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BackgroundMiddle East respiratory syndrome coronavirus (MERS-CoV) remains a major concern for global public health. Dromedaries are the source of human zoonotic infection. MERS-CoV is enzootic among dromedaries on the Arabian Peninsula, the Middle East and in Africa. Over 70% of infected dromedaries are found in Africa. However, all known zoonotic cases of MERS have occurred in the Arabian Peninsula with none being reported in Africa.AimWe aimed to investigate serological evidence of MERS-CoV infection in humans living in camel-herding areas in Morocco to provide insights on whether zoonotic transmission is taking place.MethodsWe carried out a cross sectional seroprevalence study from November 2017 through January 2018. We adapted a generic World Health Organization MERS-CoV questionnaire and protocol to assess demographic and risk factors of infection among a presumed high-risk population. ELISA, MERS-CoV spike pseudoparticle neutralisation tests (ppNT) and plaque neutralisation tests (PRNT) were used to assess MERS-CoV seropositivity.ResultsSerum samples were collected from camel slaughterhouse workers (n = 137), camel herders (n = 156) and individuals of the general population without occupational contact with camels but living in camel herding areas (n = 186). MERS-CoV neutralising antibodies with ≥ 90% reduction of plaque numbers were detected in two (1.5%) slaughterhouse workers, none of the camel herders and one individual from the general population (0.5%).ConclusionsThis study provides evidence of zoonotic transmission of MERS-CoV in Morocco in people who have direct or indirect exposure to dromedary camels.</div></front></TEI><pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">31796154</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>48</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill.</ISOAbbreviation></Journal><ArticleTitle>Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2019.24.48.1900244</ELocationID><Abstract><AbstractText>BackgroundMiddle East respiratory syndrome coronavirus (MERS-CoV) remains a major concern for global public health. Dromedaries are the source of human zoonotic infection. MERS-CoV is enzootic among dromedaries on the Arabian Peninsula, the Middle East and in Africa. Over 70% of infected dromedaries are found in Africa. However, all known zoonotic cases of MERS have occurred in the Arabian Peninsula with none being reported in Africa.AimWe aimed to investigate serological evidence of MERS-CoV infection in humans living in camel-herding areas in Morocco to provide insights on whether zoonotic transmission is taking place.MethodsWe carried out a cross sectional seroprevalence study from November 2017 through January 2018. We adapted a generic World Health Organization MERS-CoV questionnaire and protocol to assess demographic and risk factors of infection among a presumed high-risk population. ELISA, MERS-CoV spike pseudoparticle neutralisation tests (ppNT) and plaque neutralisation tests (PRNT) were used to assess MERS-CoV seropositivity.ResultsSerum samples were collected from camel slaughterhouse workers (n = 137), camel herders (n = 156) and individuals of the general population without occupational contact with camels but living in camel herding areas (n = 186). MERS-CoV neutralising antibodies with ≥ 90% reduction of plaque numbers were detected in two (1.5%) slaughterhouse workers, none of the camel herders and one individual from the general population (0.5%).ConclusionsThis study provides evidence of zoonotic transmission of MERS-CoV in Morocco in people who have direct or indirect exposure to dromedary camels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abbad</LastName><ForeName>Anass</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>These authors contributed equally to this work.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire d'Ecologie et d'Environnement, Faculté des Sciences Ben M'Sik, Université Hassan II, Casablanca, Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Ranawaka Apm</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>These authors contributed equally to this work.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, University of Hong-Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anga</LastName><ForeName>Latifa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faouzi</LastName><ForeName>Abdellah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minh</LastName><ForeName>Nhu Nguyen Tran</ForeName><Initials>NNT</Initials><AffiliationInfo><Affiliation>Health Emergencies Programme, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Sk Md Mamunur Rahman</ForeName><Initials>SMMR</Initials><AffiliationInfo><Affiliation>Health Emergencies Programme, World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iounes</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratoire d'Ecologie et d'Environnement, Faculté des Sciences Ben M'Sik, Université Hassan II, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maaroufi</LastName><ForeName>Abderrahmane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Kerkhove</LastName><ForeName>Maria D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Health Emergencies Programme, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peiris</LastName><ForeName>Malik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>HKU-Pasteur Research Pole, University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, University of Hong-Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nourlil</LastName><ForeName>Jalal</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Virology and BSL-3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>HHSN272201400006C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MERS-CoV</Keyword><Keyword MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</Keyword><Keyword MajorTopicYN="N">Morocco</Keyword><Keyword MajorTopicYN="N">dromedaries</Keyword><Keyword MajorTopicYN="N">transmission</Keyword><Keyword MajorTopicYN="N">zoonosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31796154</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.48.1900244</ArticleId><ArticleId IdType="pmc">PMC6891945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Euro Surveill. 2014 Jun 12;19(23):null</Citation><ArticleIdList><ArticleId IdType="pubmed">24957745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antiviral Res. 2018 Nov;159:63-67</Citation><ArticleIdList><ArticleId IdType="pubmed">30261226</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1049-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24856660</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2015 Mar;9(2):64-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25470665</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2014 Feb;14(2):140-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24355866</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2015 May;15(5):559-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25863564</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>MBio. 2018 Oct 30;9(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">30377284</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Trop Med Hyg. 2017 Jun;96(6):1318-1324</Citation><ArticleIdList><ArticleId IdType="pubmed">28719257</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2018 Aug;23(32):</Citation><ArticleIdList><ArticleId IdType="pubmed">30107872</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Diagn Microbiol Infect Dis. 2017 Oct;89(2):106-111</Citation><ArticleIdList><ArticleId IdType="pubmed">28821364</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1086-9</Citation><ArticleIdList><ArticleId IdType="pubmed">27071076</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2015;20(41):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26538277</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2015 Dec;21(12):2197-200</Citation><ArticleIdList><ArticleId IdType="pubmed">26584223</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2017 Feb 9;376(6):584-594</Citation><ArticleIdList><ArticleId IdType="pubmed">28177862</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2014 Jan 15;209(2):243-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24218504</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virol Sin. 2018 Oct;33(5):410-417</Citation><ArticleIdList><ArticleId IdType="pubmed">30311100</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2015 Apr;21(4):699-701</Citation><ArticleIdList><ArticleId IdType="pubmed">25811546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Epidemiol Infect. 2019 Jan;147:e84</Citation><ArticleIdList><ArticleId IdType="pubmed">30869000</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2015 Aug;21(8):1422-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26196891</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2017 Mar 30;22(13):</Citation><ArticleIdList><ArticleId IdType="pubmed">28382915</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2017 Jul;23(7):1079-1084</Citation><ArticleIdList><ArticleId IdType="pubmed">28585916</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2019 May;25(5):927-935</Citation><ArticleIdList><ArticleId IdType="pubmed">31002068</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antiviral Res. 2018 Nov;159:35-44</Citation><ArticleIdList><ArticleId IdType="pubmed">30236531</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2013 Sep 05;18(36):pii=20574</Citation><ArticleIdList><ArticleId IdType="pubmed">24079378</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3144-3149</Citation><ArticleIdList><ArticleId IdType="pubmed">29507189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000345 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000345 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:31796154
|texte= Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:31796154" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |